Tissue engaged in the transformation of iris into lens, triggered by lens removal in the adult newt (Triturus viridescens), was labeled in vitro with 14curidine, and the sedimentation profiles of RNA synthestized by the tissue were studied in sucrose density gradients. The radioactivity in the 18s a
Activated ribosomal RNA synthesis in regenerated rat liver upon inhibition of protein synthesis
โ Scribed by Emil H. Nikolov; Bistra B. Nankova; Mariana D. Dabeva
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 551 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0301-4851
No coin nor oath required. For personal study only.
โฆ Synopsis
Cycloheximide (Cyh), administered at a dose of 5 mg/kg body wt blocks protein synthesis in normal rat liver (NRL) and regenerating rat liver (RRL). The rate of synthesis of 45S pre-rRNA in RRL, studied after RNA labelling in vivo is activated 2.8 times. Pre-r RNA synthesis in RRL is more sensitive to the stopped translation, but never falls down to the level in NRL. The major contribution to the rDNA transcription activation in RRL comes from the 20-fold increase in the number of pol I molecules engaged in the transcription, the elongation rate being 1.4-fold accelerated. Cyh quenches partially the enhanced rDNA transcription in RRL: the number of pol I molecules and their elongation rate are about 1.7-fold and 1.5-fold higher, respectively, than the corresponding values in NRL after Cyh treatment. The results show that two different mechanisms control the number and the rate of initiation and elongation of RNA polymerase I in rat liver; one of them depends on continuous protein synthesis and can be inactivated by Cyh, the other is Cyh resistant.
๐ SIMILAR VOLUMES
The effect of regucalcin, a Ca(2+)-binding protein isolated from rat liver cytosol, on deoxyribonucleic acid (DNA) synthesis in the nuclei of regenerating rat liver was investigated. At 1 day after partial hepatectomy, the liver weight was increased about 50% of that of sham-operated rats, and it re
Tacrine (tetrahydroaminoacridine) is currently the only drug approved for the treatment of Alzheimer's disease. Unfortunately, tetrahydroaminoacridine therapy is often limited by this drug's propensity to induce reversible hepatotoxicity. Using suspensions of freshly isolated rat hepatocytes, we inv